---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-099740"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:43:21.262060+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Carisma Therapeutics terminates CEO (eff. Nov 15) and CSO; three directors resign

## Summary
- CEO Steven Kelly terminated without cause, effective Nov 15, 2025; gets $624K severance plus $299,948 prorated bonus and health payments.
- CSO Michael Klichinsky terminated without cause, effective Oct 15, 2025; receives 12 months salary in installments, prorated bonus, $2,245/month health payment.
- Directors John Hohneker, Briggs Morrison, David Scadden resigned Oct 15; Kelly resigns from board effective Nov 15.
- Company will appoint a consultant as CEO to manage wind-down; prior retention bonus agreement with Kelly voided.
- Wind-down of operations previously disclosed; no disagreement cited for director resignations.

## SEC filing metadata
- accession: 0001104659-25-099740
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465925099740/0001104659-25-099740-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465925099740/tm2528741d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-099740
- JSON: https://secwatch.observer/filing/0001104659-25-099740.json
- Plain text: https://secwatch.observer/filing/0001104659-25-099740.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.